Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F0BFT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,405
Award facts
- Contract value 100% obligated
- $17,405.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $17,405.43 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for COSENTYX (secukinumab) 300 mg dose, 2 pens/mL.
Place of performance is Conshohocken, PA. The order carries a firm fixed price structure with an ultimate completion date of April 20, 2026. No set-aside was applied. Amerisourcebergen is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on a full-and-open basis for federal healthcare procurement.
Quick answers
Who was awarded contract SPE2DR26F0BFT?
SPE2DR26F0BFT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 17, 2026.
How much is contract SPE2DR26F0BFT worth?
The government has obligated $17,405 on SPE2DR26F0BFT.
Is contract SPE2DR26F0BFT an order under another contract?
Yes. SPE2DR26F0BFT is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0BFT competed?
The extent of competition for SPE2DR26F0BFT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award